Camber Capital Management LP Myriad Genetics Inc Transaction History

Camber Capital Management LP

  • $1.02 Billion
  • Q2 2025

A detailed history of Camber Capital Management LP transactions in Myriad Genetics Inc stock. As of the latest transaction made, Camber Capital Management LP holds 2,000,000 shares of MYGN stock, worth $13.4 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares
2,000,000
Previous 2,350,000 14.89%
Holding current value
$13.4 Million
Previous $20.8 Million 49.05%
% of portfolio
1.05%
Previous 0.78%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$3.84 - $8.84 $1.34 Million - $3.09 Million
-350,000 Reduced 14.89%
2,000,000 $10.6 Million
Q1 2025

May 15, 2025
SELL
$8.87 - $14.98 $6.65 Million - $11.2 Million
-750,000 Reduced 24.19%
2,350,000 $20.8 Million
Q4 2024

Feb 14, 2025
SELL
$13.17 - $27.03 $11.2 Million - $23 Million
-850,000 Reduced 21.52%
3,100,000 $42.5 Million
Q3 2024

Nov 14, 2024
SELL
$23.97 - $28.6 $37.2 Million - $44.3 Million
-1,550,000 Reduced 28.18%
3,950,000 $108 Million
Q2 2024

Aug 14, 2024
SELL
$17.98 - $25.47 $38.4 Million - $54.4 Million
-2,135,000 Reduced 27.96%
5,500,000 $135 Million
Q4 2023

Feb 14, 2024
BUY
$13.91 - $21.32 $13.9 Million - $21.3 Million
1,000,000 Added 15.07%
7,635,000 $146 Million
Q2 2023

Aug 14, 2023
SELL
$17.56 - $23.76 $6.41 Million - $8.67 Million
-365,000 Reduced 5.21%
6,635,000 $154 Million
Q4 2022

Feb 14, 2023
BUY
$14.51 - $20.99 $29 Million - $42 Million
2,000,000 Added 40.0%
7,000,000 $102 Million
Q2 2022

Aug 15, 2022
BUY
$16.45 - $25.88 $24.7 Million - $38.8 Million
1,500,000 Added 42.86%
5,000,000 $90.9 Million
Q1 2022

May 16, 2022
BUY
$22.67 - $28.01 $17 Million - $21 Million
750,000 Added 27.27%
3,500,000 $88.2 Million
Q3 2021

Nov 15, 2021
SELL
$29.97 - $36.66 $7.49 Million - $9.17 Million
-250,000 Reduced 8.33%
2,750,000 $88.8 Million
Q1 2021

May 17, 2021
SELL
$19.92 - $31.6 $39.8 Million - $63.2 Million
-2,000,000 Reduced 40.0%
3,000,000 $91.4 Million
Q3 2020

Nov 16, 2020
BUY
$11.25 - $14.75 $11.3 Million - $14.8 Million
1,000,000 Added 25.0%
5,000,000 $65.2 Million
Q2 2020

Aug 14, 2020
BUY
$10.69 - $16.49 $17.6 Million - $27.2 Million
1,650,000 Added 70.21%
4,000,000 $45.4 Million
Q1 2020

May 15, 2020
BUY
$9.78 - $29.53 $13.2 Million - $39.9 Million
1,350,000 Added 135.0%
2,350,000 $33.6 Million
Q3 2019

Nov 14, 2019
BUY
$22.08 - $47.08 $22.1 Million - $47.1 Million
1,000,000 New
1,000,000 $28.6 Million
Q3 2018

Nov 14, 2018
SELL
$37.57 - $50.34 $56.4 Million - $75.5 Million
-1,500,000 Closed
0 $0
Q4 2017

Feb 14, 2018
SELL
$28.45 - $37.14 $14.2 Million - $18.6 Million
-500,000 Reduced 25.0%
1,500,000 $51.5 Million
Q3 2017

Nov 14, 2017
BUY
$24.01 - $36.2 $48 Million - $72.4 Million
2,000,000
2,000,000 $72.4 Million

Others Institutions Holding MYGN

# of Institutions
238
Shares Held
92.1M
Call Options Held
86.1K
Put Options Held
18.9K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $541M
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Camber Capital Management LP Portfolio

Follow Camber Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Camber Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email